505(b)(2)
LXPB5101
LXPB5101 was originally developed as a medication for hypertension and was later further developed for cancer treatment.
Indications
Pancreatic cancer
Latest Progress
Preclinical
IND
Phase 1
Phase 2
Phase 3
Market
Preparations for the verification clinical trial are underway
Patents
New patents for cancer treatment indications have been obtained in Taiwan, Australia, South Korea, and Europe.
- Taiwan
- United States
- Korea
- Australia
- Europe
